A citation-based method for searching scientific literature

Carolyn C Compton, Frederick L Greene. CA Cancer J Clin 2004
Times Cited: 306

List of co-cited articles
390 articles co-cited >1

Times Cited
  Times     Co-cited

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.
C C Compton, L P Fielding, L J Burgart, B Conley, H S Cooper, S R Hamilton, M E Hammond, D E Henson, R V Hutter, R B Nagle,[...]. Arch Pathol Lab Med 2000

Lymph node evaluation and survival after curative resection of colon cancer: systematic review.
George J Chang, Miguel A Rodriguez-Bigas, John M Skibber, Virginia A Moyer. J Natl Cancer Inst 2007

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.
Robert L Camp, Marisa Dolled-Filhart, David L Rimm. Clin Cancer Res 2004

Colorectal cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ann Goding Sauer, Stacey A Fedewa, Lynn F Butterly, Joseph C Anderson, Andrea Cercek, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2020

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.
T E Le Voyer, E R Sigurdson, A L Hanlon, R J Mayer, J S Macdonald, P J Catalano, D G Haller. J Clin Oncol 2003

Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy.
Anand Govindarajan, Mithat Gönen, Martin R Weiser, Jinru Shia, Larissa K Temple, Jose G Guillem, Philip B Paty, Garrett M Nash. J Clin Oncol 2011

Impact of number of nodes retrieved on outcome in patients with rectal cancer.
J E Tepper, M J O'Connell, D Niedzwiecki, D Hollis, C Compton, A B Benson, B Cummings, L Gunderson, J S Macdonald, R J Mayer. J Clin Oncol 2001

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
H J Schmoll, E Van Cutsem, A Stein, V Valentini, B Glimelius, K Haustermans, B Nordlinger, C J van de Velde, J Balmana, J Regula,[...]. Ann Oncol 2012

Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis.
Nancy N Baxter, Arden M Morris, David A Rothenberger, Joel E Tepper. Int J Radiat Oncol Biol Phys 2005

Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Leopoldo Sarli, Giovanni Bader, Domenico Iusco, Carlo Salvemini, Davide Di Mauro, Antonio Mazzeo, Gabriele Regina, Luigi Roncoroni. Eur J Cancer 2005

Colorectal cancer.
Hermann Brenner, Matthias Kloor, Christian Peter Pox. Lancet 2014

Less than 12 nodes in the surgical specimen after total mesorectal excision following neoadjuvant chemoradiation: it means more than you think!
Luiz Felipe de Campos-Lobato, Luca Stocchi, João Batista de Sousa, Martin Buta, Ian C Lavery, Victor W Fazio, David W Dietz, Matthew F Kalady. Ann Surg Oncol 2013

Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival.
Anne Rullier, Christophe Laurent, Maylis Capdepont, Véronique Vendrely, Geneviève Belleannée, Paulette Bioulac-Sage, Eric Rullier. Am J Surg Pathol 2008

AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?
Danielle M Hari, Anna M Leung, Ji-Hey Lee, Myung-Shin Sim, Brooke Vuong, Connie G Chiu, Anton J Bilchik. J Am Coll Surg 2013

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
Richard Gray, Jennifer Barnwell, Christopher McConkey, Robert K Hills, Norman S Williams, David J Kerr. Lancet 2007

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Al B Benson, Deborah Schrag, Mark R Somerfield, Alfred M Cohen, Alvaro T Figueredo, Patrick J Flynn, Monika K Krzyzanowska, Jean Maroun, Pamela McAllister, Eric Van Cutsem,[...]. J Clin Oncol 2004

Cancer statistics, 2013.
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal. CA Cancer J Clin 2013

Preoperative versus postoperative chemoradiotherapy for rectal cancer.
Rolf Sauer, Heinz Becker, Werner Hohenberger, Claus Rödel, Christian Wittekind, Rainer Fietkau, Peter Martus, Jörg Tschmelitsch, Eva Hager, Clemens F Hess,[...]. N Engl J Med 2004

Colorectal cancer statistics, 2014.
Rebecca Siegel, Carol Desantis, Ahmedin Jemal. CA Cancer J Clin 2014

Has the new TNM classification for colorectal cancer improved care?
Iris D Nagtegaal, Phil Quirke, Hans-Joachim Schmoll. Nat Rev Clin Oncol 2011

Cancer statistics in China, 2015.
Wanqing Chen, Rongshou Zheng, Peter D Baade, Siwei Zhang, Hongmei Zeng, Freddie Bray, Ahmedin Jemal, Xue Qin Yu, Jie He. CA Cancer J Clin 2016

Colorectal cancer statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Stacey A Fedewa, Dennis J Ahnen, Reinier G S Meester, Afsaneh Barzi, Ahmedin Jemal. CA Cancer J Clin 2017

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018

Analyzing real-time PCR data by the comparative C(T) method.
Thomas D Schmittgen, Kenneth J Livak. Nat Protoc 2008

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
Thierry André, Corrado Boni, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Andrea Bonetti, Philip Clingan, John Bridgewater, Fernando Rivera,[...]. J Clin Oncol 2009

Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging.
G Brown, A G Radcliffe, R G Newcombe, N S Dallimore, M W Bourne, G T Williams. Br J Surg 2003

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Claus Rödel, Peter Martus, Thomas Papadoupolos, Laszlo Füzesi, Martin Klimpfinger, Rainer Fietkau, Torsten Liersch, Werner Hohenberger, Rudolf Raab, Rolf Sauer,[...]. J Clin Oncol 2005

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Marta Zaninelli, Philip Clingan, John Bridgewater,[...]. N Engl J Med 2004

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Sharlene Gill, Charles L Loprinzi, Daniel J Sargent, Stephan D Thomé, Steven R Alberts, Daniel G Haller, Jacqueline Benedetti, Guido Francini, Lois E Shepherd, Jean Francois Seitz,[...]. J Clin Oncol 2004

MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer.
Beomseok Sohn, Joon-Seok Lim, Honsoul Kim, Sungmin Myoung, Junjeong Choi, Nam Kyu Kim, Myeong-Jin Kim. Eur Radiol 2015

From Dukes through Jass: pathological prognostic indicators in rectal cancer.
J C Harrison, P J Dean, F el-Zeky, R Vander Zwaag. Hum Pathol 1994

A systematic approach to the interpretation of preoperative staging MRI for rectal cancer.
Fiona G M Taylor, Robert I Swift, Lennart Blomqvist, Gina Brown. AJR Am J Roentgenol 2008

Lymph node evaluation in colorectal cancer patients: a population-based study.
Nancy N Baxter, Dan J Virnig, David A Rothenberger, Arden M Morris, Jose Jessurun, Beth A Virnig. J Natl Cancer Inst 2005

Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery.
Nader N Massarweh, Chung-Yuan Hu, Y Nancy You, Brian K Bednarski, Miguel A Rodriguez-Bigas, John M Skibber, Scott B Cantor, Janice N Cormier, Barry W Feig, George J Chang. J Clin Oncol 2014

miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma.
Panagiotis G Adamopoulos, Christos K Kontos, Stamatia-Maria Rapti, Iordanis N Papadopoulos, Andreas Scorilas. Int J Oncol 2015

MicroRNA signatures in human cancers.
George A Calin, Carlo M Croce. Nat Rev Cancer 2006

Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients.
Stamatia-Maria Rapti, Christos K Kontos, Iordanis N Papadopoulos, Andreas Scorilas. Clin Chem Lab Med 2014

Oncomirs - microRNAs with a role in cancer.
Aurora Esquela-Kerscher, Frank J Slack. Nat Rev Cancer 2006

MicroRNA signatures: novel biomarker for colorectal cancer?
Xiaoya Luo, Barbara Burwinkel, Sha Tao, Hermann Brenner. Cancer Epidemiol Biomarkers Prev 2011

Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience.
S M Steinberg, J S Barkin, R S Kaplan, D M Stablein. Cancer 1986

Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
Hak-Mien Quah, Joanne F Chou, Mithat Gonen, Jinru Shia, Deborah Schrag, Leonard B Saltz, Karyn A Goodman, Bruce D Minsky, W Douglas Wong, Martin R Weiser. Cancer 2008

Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Li-Jen Kuo, Mei-Ching Liu, James Jer-Min Jian, Cheng-Fang Horng, Tsun-I Cheng, Chung-Ming Chen, Wei-Tse Fang, Yih-Lin Chung. Ann Surg Oncol 2007

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.